
Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients
Author(s) -
Shiheng Zhang,
Lan He,
Nan Dai,
Wei Guan,
Jinlu Shan,
Xueqin Yang,
Zhaoyang Zhong,
Yi Qu,
Feng Jin,
Chuan Chen,
Yuxin Yang,
Hongyi Wang,
Laura Baugh,
Gianluca Tell,
David M. Wilson,
Mengxia Li,
Dong Wang
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.13030
Subject(s) - medicine , lung cancer , cancer , chemotherapy , oncology
To define the role of the DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1) in predicting the prognosis and chemotherapeutic response of non-small cell lung cancer patients receiving platinum-containing chemotherapy.